Dhruva Biswas

Title: Dhruva Biswas: Innovator in Cancer Prognosis

Introduction

Dhruva Biswas is a notable inventor based in London, GB. He has made significant contributions to the field of cancer research, particularly in developing methods for predicting survival rates for lung cancer patients. His innovative approach combines biological samples with advanced biomarker analysis to provide accurate prognoses.

Latest Patents

Dhruva Biswas holds a patent for a method of predicting survival rates for cancer patients. This invention involves contacting a biological sample from a subject with specific reagents that bind to a panel of biomarkers. The method includes determining a risk score based on the nucleic acid levels of expression of these biomarkers and providing a prognosis for lung cancer based on the calculated risk score. He has 1 patent to his name.

Career Highlights

Throughout his career, Dhruva has worked with prestigious institutions such as the Francis Crick Institute Limited and University College London. His work has been instrumental in advancing cancer prognosis methodologies, showcasing his dedication to improving patient outcomes.

Collaborations

Dhruva has collaborated with esteemed colleagues, including Robert Charles Swanton and Nicholas McGranahan. These partnerships have further enriched his research and contributed to the development of innovative cancer treatment strategies.

Conclusion

Dhruva Biswas is a pioneering inventor whose work in cancer prognosis is making a significant impact in the medical field. His innovative methods and collaborations highlight the importance of research in improving patient care and outcomes.